Literature DB >> 17541765

Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.

Hyung-Won Jeon1, Jae-Kwan Cha.   

Abstract

Atherosclerosis plays an important role in ischemic stroke. We conducted this prospective study to determine significant factors related to progression of middle cerebral artery (MCA) stenosis. We studied 103 patients with MCA stenosis using transcranial Doppler (TCD) and re-evaluated the TCD results at 6 months after the initial investigation and measured platelet aggregability for adenosine diphosphate (ADP) or arachidonic acid (AA). After 6 months, 13 (12.6%) patients showed worsening, whereas 90 were stationary or showed regression upon TCD examination. In a univariate analysis, the history of ischemic stroke (P=0.023), the presence of significant carotid stenosis (P=0.027), the prescription of aspirin only (P=0.046), the grade of stenosis in the MRA (P=0.0048), and the platelet aggregability for ADP (P=0.015) were significantly associated with the progression of MCA stenosis. After multiple logistic regression analysis, the grades of stenosis and platelet aggregability for ADP were independent factors related to the progression of MCA stenosis. In this study, the grade of MCA stenosis on angiography might be an important factor to predict the progression upon serial TCD examination. Also, the extent of inhibition of platelet activation could be a possible role to determine on the progression of MCA stenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541765     DOI: 10.1007/s11239-007-0049-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  19 in total

1.  Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease.

Authors:  R Kern; W Steinke; M Daffertshofer; R Prager; M Hennerici
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

2.  Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque.

Authors:  G A Lammie; P A Sandercock; M S Dennis
Journal:  Stroke       Date:  1999-07       Impact factor: 7.914

3.  Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors?

Authors:  D Inzitari; V C Hachinski; D W Taylor; H J Barnett
Journal:  Arch Neurol       Date:  1990-10

4.  Prognostic factors and therapeutic outcome of isolated symptomatic middle cerebral artery stenosis.

Authors:  N-W Tsai; H-W Chang; W-N Chang; C-R Huang; T-K Lin; S-D Chen; C-C Lui; K-W Wang; B-C Cheng; P-L Hung; C-S Chang; C-H Lu
Journal:  Eur J Neurol       Date:  2005-07       Impact factor: 6.089

5.  Yield of transcranial Doppler in acute cerebral ischemia.

Authors:  A V Alexandrov; A M Demchuk; T H Wein; J C Grotta
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

6.  Cerebral hemispheric low-flow infarcts in arterial occlusive disease. Lesion patterns and angiomorphological conditions.

Authors:  M Mull; M Schwarz; A Thron
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

7.  Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.

Authors:  Jae-Kwan Cha; Min-Ho Jeong; Kyung-Mi Lee; Hae-Rahn Bae; Yeong-Jin Lim; Kyung Won Park; Sang-Myung Cheon
Journal:  J Thromb Thrombolysis       Date:  2002-10       Impact factor: 2.300

8.  Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

Authors:  Gianluca Campo; Marco Valgimigli; Donato Gemmati; Gianfranco Percoco; Silvia Tognazzo; Giordano Cicchitelli; Linda Catozzi; Patrizia Malagutti; Maurizio Anselmi; Corrado Vassanelli; Gianluigi Scapoli; Roberto Ferrari
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

9.  Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.

Authors:  Sun U Kwon; Yong-Jin Cho; Ja-Seong Koo; Hee-Joon Bae; Yong-Seok Lee; Keun-Sik Hong; Jun Hong Lee; Jong S Kim
Journal:  Stroke       Date:  2005-03-03       Impact factor: 7.914

10.  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

View more
  1 in total

Review 1.  Natural history of intracranial atherosclerotic disease.

Authors:  Yuehua Pu; Xin Dou; Liping Liu
Journal:  Front Neurol       Date:  2014-07-10       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.